These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9263702

  • 1. Steroid abuse in female athletes.
    Honour JW.
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):181-6. PubMed ID: 9263702
    [Abstract] [Full Text] [Related]

  • 2. Medicine and science in the fight against doping in sport.
    Catlin DH, Fitch KD, Ljungqvist A.
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry.
    Thevis M, Sauer M, Geyer H, Sigmund G, Mareck U, Schänzer W.
    J Sports Sci; 2008 Aug; 26(10):1059-65. PubMed ID: 18608840
    [Abstract] [Full Text] [Related]

  • 8. Drug testing in elite athletes--the Israeli perspective.
    Epstein S, Eliakim A.
    Isr Med Assoc J; 1999 Oct; 1(2):79-82. PubMed ID: 10731300
    [Abstract] [Full Text] [Related]

  • 9. [Dangers and risks of black market anabolic steroid abuse in sports --gas chromatography-mass spectrometry analyses].
    Ritsch M, Musshoff F.
    Sportverletz Sportschaden; 2000 Mar; 14(1):1-11. PubMed ID: 10859788
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM, Diallo B, Fall A, Ndiaye M, Cissè F, Faye B.
    Sante; 2005 Mar; 15(3):167-70. PubMed ID: 16207578
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
    Curry LA, Wagman DF.
    Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
    [Abstract] [Full Text] [Related]

  • 15. The International Olympic Committee (IOC) and GH-2000.
    Sönksen P.
    Growth Horm IGF Res; 2009 Aug; 19(4):341-5. PubMed ID: 19473864
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.
    Smith R, Barnsley L, Kannangara S, Mace A.
    Rheumatology (Oxford); 2004 Dec; 43(12):1473-5. PubMed ID: 15292526
    [Abstract] [Full Text] [Related]

  • 19. Detection of GH abuse in sport: Past, present and future.
    Barroso O, Schamasch P, Rabin O.
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [Abstract] [Full Text] [Related]

  • 20. Protein chips for high-throughput doping screening in athletes.
    Du H, Cheng J.
    Expert Rev Proteomics; 2006 Feb; 3(1):111-4. PubMed ID: 16445355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.